Submitted by Anonymous (not verified) on 3 July 2026 - 10:00
Opinion/decision on a Paediatric investigation plan (PIP): Nexviadyme, avalglucosidase alfa, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000238632
Source: